Scientific article
OA Policy
English

Bridging the gap: immunotherapy in progressive multifocal leukoencephalopathy: a new hope?

Published inNeurology, 10.1212/WNL.0000000000207533
Publication date2023-07-05
First online date2023-07-05
Abstract

Progressive multifocal leukoencephalopathy (PML) is a severe infection of the central nervous system occurring in immunocompromised individuals in which large demyelinating lesions are induced by polyomavirus JC (JCV). In the absence of effective antiviral treatment, control of the infection relies on restoring anti-JCV immunity. Thus, particularly in longstanding immunocompromising conditions such as organ transplantation, lymphoproliferative disorders, or idiopathic lymphopenia, new strategies to boost anti-JCV immune responses are needed. Here, we report the case of a patient developing PML in the context of kidney transplantation who received rh-IL-7 to foster immune responses against JCV. We give an overview of the immunological mechanisms underlying the development of PML and immune restoration within the central nervous system following JCV infection. Immunotherapeutic strategies developed based on current understanding of the disease hold promise in managing patients with PML.

Citation (ISO format)
BORN, Tristan et al. Bridging the gap: immunotherapy in progressive multifocal leukoencephalopathy: a new hope? In: Neurology, 2023, p. 10.1212/WNL.0000000000207533. doi: 10.1212/WNL.0000000000207533
Main files (1)
Article (Accepted version)
accessLevelPublic
Identifiers
Journal ISSN0028-3878
113views
181downloads

Technical informations

Creation07/08/2023 09:08:25
First validation07/08/2023 12:55:21
Update07/08/2023 12:55:21
Status update07/08/2023 12:55:21
Last indexation01/11/2024 05:45:03
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack